Markets › United States › NAS › BNGO

Bionano Genomics Inc

NAS:BNGOHealthcarenasdaq_composite

$1.28+4.92%LiveIn session · ≈ AED 4.70 · Market cap $15.07M · Next earnings Thu 29 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	32.6%	21.5%	21.4%	26.5%	1.2%	22.0%	—	—
Operating margin	−453.4%	−428.8%	−473.7%	−596.0%	−337.9%	−116.9%	−116.9%	+0.0 pts
Net margin	−483.4%	−402.8%	−476.9%	−643.7%	−364.0%	−92.6%	−92.6%	+0.0 pts
EBITDA margin	−418.3%	−410.7%	−432.8%	−591.4%	−316.7%	−57.2%	—	—
Return on equity	−117.2%	−21.5%	−53.2%	−241.8%	−316.7%	−59.4%	−59.4%	+0.0 pts
Return on assets	−68.0%	−19.2%	−43.1%	−108.4%	−146.1%	−35.9%	−35.9%	+0.0 pts
Return on capital employed	−74.8%	−21.7%	−48.5%	−188.2%	−264.4%	−65.8%	—	—
Debt / equity	0.5×	0.0×	0.0×	0.8×	0.8×	0.2×	0.2×	+0.0%
Debt / assets	27.0%	2.8%	3.8%	37.0%	35.6%	9.4%	—	—
Interest coverage	−15.3×	−83.2×	−441.9×	−42.0×	−359.8×	−111.9×	—	—
Current ratio	5.2×	12.5×	4.4×	1.4×	1.1×	2.0×	2.0×	+0.0%
Quick ratio	4.9×	11.9×	3.6×	1.2×	0.8×	1.7×	—	—
Cash ratio	4.3×	1.1×	0.1×	0.2×	0.2×	0.1×	0.1×	+0.0%
Asset turnover	0.1×	0.0×	0.1×	0.2×	0.4×	0.4×	—	—
Inventory turnover	1.7×	1.1×	0.7×	1.2×	2.7×	4.1×	—	—
Receivables turnover	3.1×	3.4×	3.7×	3.7×	6.4×	5.5×	—	—
Dividend payout	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	—	—